NCT01288625 2021-11-17
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Sun Pharmaceutical Industries Limited
Phase 4 Withdrawn
Clinical Trials
3 trialsNCT00086099 2009-01-29
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia
MedImmune LLC
Phase 1/2 Completed
NCT00081315 2007-08-21
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
MedImmune LLC
Phase 2 Completed